Home > Insider Trading > Filing (0001209191-20-030893)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1000694	Novavax Inc	NVAX	Biological Products, (No Disgnostic Substances) (2836)	222816046

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1610928	Iii A John Herrmann	C/O Novavax, Inc. 21 Firstfield Road Gaithersburg MD 20878	Svp, General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-05-18	7,499	$25.60	7,774	No	4	M	Direct
Common Stock	Disposition	2020-05-18	7,499	$49.44	275	No	4	S	Direct
Common Stock	Acquisiton	2020-05-18	5,462	$27.00	5,737	No	4	M	Direct
Common Stock	Disposition	2020-05-18	5,462	$49.44	275	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to buy)	Disposition	2020-05-18	7,499	$0.00	7,499	$25.60
Common Stock	Stock Option (Right to buy)	Disposition	2020-05-18	5,462	$0.00	5,462	$27.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2022-03-01	No	4	M	Direct
787		2026-11-14	No	4	M	Direct

Footnotes

The shares subject to this option grant under the Novavax, Inc. 2005 Stock Incentive Plan, as amended, vested in four equal annual installments on the first four anniversaries of the March 1, 2012 grant date.
Twenty-five percent (25%) of the shares subject to this option grant under the Novavax, Inc. 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the November 14, 2016 grant date, and the remaining seventy-five percent (75%) of the shares vested in equal monthly installments over the following three years.